JPRN-jRCTs031220226招募中未知
A clinical study to investigate the intracerebral dynamics of [18F]K-40 in healthy volunteers.
Ichijo Sadamitsu0 个研究点目标入组 5 人开始时间: 2022年7月27日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 5
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 < 40age old（—）
- 性别
- Male
入选标准
- •1. Males between 20 and 40 years old at the time of obtaining informed consent.
- •2. Males who have no history of neuropsychiatric disorders.
- •3. Males who have the ability to express a choice in the MacArthur Competence Assessment Tool (MacCAT), and written consents are provided by them
- •4. Males who have no current mental disorders without meeting any criteria in SCID-I /DSM-IV,DSM-5, ICD-10.
排除标准
- •1. Males who are taking psychotropic drugs, antidepressant, hypnotic, anxiolytic, antipsychotic.
- •2. Males who are taking prescription drugs other than those listed in criteria1 and cannot stop taking them one week prior to the PET examinations.
- •3. Males who are known to be hypersensitive to ethanol.
- •4. Males who have neurological diseases (neurodegenerative disease, minor cerebral hemorrhage or cerebral infarction).
- •5. Males who have history of brain tumor.
- •6. Males who have history of epilepsy.
- •7. Males who are taking medical treatment for other diseases.
- •8. Males who have substance-related disorders within 6 months except for nicotine and caffeine.
- •9. Males who show positive to addiction drugs in urine drug screening.
- •10. Males who have a pacemaker or any metal devices in the body.
- •11. Males whose head, neck and body size are not suitable for MRI scanner.
- •12. Males who have big tattoos and art makeups on their skins.
- •13. Males who have severe claustrophobia.
- •14. Males who have congenital or traumatic brain abnormalities.
- •15. Males who have abnormal laboratory standard values in blood test, biochemical test, coagulation / fibrinolysis system test, urinalysis at the time of screening (However, the case whose data is considered safe by the investigator or the sub-investigator in terms of comprehensive medical findings can be permitted to participate).
- •16. Males who have abnormal 12-lead ECG and vital signs at the screening (e.g. Systolic blood pressure 140 mmHg or higher, pulse 80 bpm or higher, body temperature 37.5 degrees or higher). (However, the case whose data is considered safe by the investigator or the sub-investigator in terms of comprehensive medical findings can be permitted to participate)
- •17. Males who show positive to at least one of the infectious disease tests (HBV, HCV, HIV, syphilis).
- •18. Males who donate 400 mL whole blood within 3 months, 200 mL whole blood within 1 month, or component blood within 2 weeks prior to the PET examinations.
- •19. Males who undertake an unapproved nuclear medicine tests or clinical trials within 6 months prior to registration.
- •20. Males who participate other clinical trials within 12 weeks prior to registration.
- •21. Males who are considered inappropriate for registration by other reasons but listed above.
研究者
相似试验
进行中（未招募）
1 期
Intracerebral Gene therapy in children with Sanfilippo type B syndromeMucopolysaccharidosis III BMedDRA version: 17.0Level: PTClassification code 10056890Term: Mucopolysaccharidosis IIISystem Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2012-000856-33-FRInstitut Pasteur
尚未招募
不适用
Pilot study to distinguish between intracerebral hemorrhage and ischemic stroke using a non-invasive acustoscerebrography in combination with established serum biomarkers.I63I61Intracerebral haemorrhageCerebral infarctionDRKS00021724ZNN, Klinik für Neurologie Universitätsklinikum Frankfurt a.M.40
招募中
不适用
The study to investigate quantitative neurological examinations for diagnosis and staging of diabetic polyneuropathyDiabetic polyneuropathyJPRN-UMIN000021916Aichi Medical University60
招募中
2 期
Study of Cyclodxtrin Therapy for Niemann-Pick disease Type Ciemann-Pick disase, type CLysozome disease, cholesterolD052556JPRN-jRCTs071190008Matsuo Muneaki3
已完成
不适用
The exploratory study about the neurophysiological index which predicts the effect of the methylphenidate hydrochloride in children with AD/HDAttention deficit hyperactivity disorderJPRN-UMIN000001270niversity of Tokyo Medical School The department of Psychiatry30